Dow Jones

40 793,63

1,45%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
30/08/2013	17h59	Business Wire	Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associa...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/08/2013	21h46	Business Wire	Leading Proxy Advisory Firms Recommend Vote in Favor of All Proposals for Teva Pharmaceutical's Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
13/08/2013	22h16	Business Wire	Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/08/2013	14h58	PR Newswire (US)	Teva Pharmaceuticals And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/08/2013	22h01	PR Newswire (Canada)	OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quart...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/08/2013	16h29	Business Wire	Teva Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/08/2013	19h53	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/08/2013	18h21	Edgar (US Regulatory)	Certification of No Change in Definitive Materials. (497j)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/08/2013	13h00	Business Wire	Teva Reports Second Quarter 2013 Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/07/2013	21h51	Business Wire	English Court of Appeal Finds in Favor of Teva on Copaxone® Patent Litigation & Upholds Validity of Copaxone Patent until Ma...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/07/2013	14h21	Edgar (US Regulatory)	Annual Report (management Company) (nsar-b)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/07/2013	14h00	Business Wire	The Potential for New Therapeutic Approaches: Global Research Collaboration Examines Multiple Pathways of Neuroprotection in ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/07/2013	19h24	Business Wire	Teva Provides Update on COPAXONE® Litigation	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
25/07/2013	07h40	Business Wire	Teva and Lonza Announce Mutual Decision to Discontinue Biologics Joint Venture	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/07/2013	14h00	PR Newswire (US)	FDA Designations to Development Programs and Quarterly Financial Results Schedules - Research Report on Valeant, Elan, Alkerm...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/07/2013	13h51	Business Wire	A "Network of Excellence" (NNE) Collaboration: Directed to Novel Therapeutic Approaches in Neurodegenerative Diseases	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/07/2013	19h14	Business Wire	Teva to Report Second Quarter 2013 Financial Results on August 1, 2013	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/07/2013	21h53	Dow Jones News	Medicines Co. Receives Unfavorable Claim Construction Ruling in Patent Suit	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
10/07/2013	17h39	Edgar (US Regulatory)	Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/07/2013	14h00	Business Wire	Phase III Data Published in Annals of Neurology Show That a Higher Concentration Dose of Glatiramer Acetate Given Three Times...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/07/2013	13h41	Dow Jones News	Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
24/06/2013	13h00	Business Wire	Teva Launches Generic Version of Viagra® (sildenafil) in Countries Across Europe	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/06/2013	18h58	Business Wire	FDA Approves Over-the-Counter Availability of Plan B One-Step® (levonorgestrel) for All Consumers	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/06/2013	05h10	Dow Jones News	FDA Lifts Age Limits On Plan B	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
19/06/2013	17h00	Dow Jones News	Teva to Disclose Individual Executives' Pay	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
19/06/2013	16h15	Dow Jones News	Teva to Disclose Individual Executives' Pay as Part of Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
18/06/2013	15h29	Dow Jones News	Biogen's New Multiple Sclerosis Drug to Test Recent Stock Gains	NYSE:TEVA	Teva Pharmaceutical Industries Ltd.
17/06/2013	16h34	Dow Jones News	Teva Agrees to Acquire MicroDose Therapeutx in Potential $165 Million Deal	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/06/2013	15h30	Business Wire	Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/06/2013	15h15	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH	NYSE:TEVA	Teva Pharmaceutical Industries Ltd